Target Details
| UniProt AC | P49841 |
|---|---|
| Gene Symbol | GSK3B |
| Protein Name | Glycogen synthase kinase-3 beta |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00069 (Pkinase) |
Summary
- Multi-target molecules 2,206
- Clinical molecules 168
- Avg pChEMBL 7.19
KEGG Pathways (49)
- Alcoholic liver disease
- Alzheimer disease
- Axon guidance
- B cell receptor signaling pathway
- Basal cell carcinoma
- Breast cancer
- Cadherin signaling
- Cell cycle
- Chemokine signaling pathway
- Colorectal cancer
- Cushing syndrome
- Diabetic cardiomyopathy
- Dopaminergic synapse
- EGFR tyrosine kinase inhibitor resistance
- Endometrial cancer
- ErbB signaling pathway
- Focal adhesion
- Gastric cancer
- Growth hormone synthesis, secretion and action
- Hedgehog signaling pathway
- Hepatitis C
- Hepatocellular carcinoma
- Hippo signaling pathway
- Human cytomegalovirus infection
- Human papillomavirus infection
- IL-17 signaling pathway
- IgSF CAM signaling
- Insulin resistance
- Insulin signaling pathway
- Integrin signaling
- Kaposi sarcoma-associated herpesvirus infection
- Lipid and atherosclerosis
- Measles
- Melanogenesis
- Neurotrophin signaling pathway
- Non-alcoholic fatty liver disease
- PI3K-Akt signaling pathway
- Pathways in cancer
- Pathways of neurodegeneration - multiple diseases
- Prion disease
- Prolactin signaling pathway
- Prostate cancer
- Shigellosis
- Signaling pathways regulating pluripotency of stem cells
- T cell receptor signaling pathway
- Thyroid hormone signaling pathway
- Wnt signaling pathway
- Yersinia infection
- mTOR signaling pathway
Active Molecules (2,206)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
KQGNXKLJTGXPAE
|
6.3 | IC50 | 2 | — | |
KTVHDHHCBGGWDN
|
6.3 | IC50 | 2 | — | |
LDMZVTUZLQEDAS
|
6.3 | IC50 | 2 | — | |
LGEZEBKXLTUWAS
|
6.3 | IC50 | 2 | — | |
LIJRMNOEEZGHRI
|
6.3 | IC50 | 2 | — | |
LJIQIUQMHCYDPG
|
6.3 | IC50 | 2 | — | |
LLQWBSMKRKPLRF
|
6.3 | IC50 | 2 | — | |
LQYLKYFKOACEGO
|
6.3 | IC50 | 2 | — | |
LUSCLWPRGPAMNG
|
6.3 | IC50 | 2 | — | |
MAXXFIYRFVWCFU
|
6.3 | IC50 | 2 | — | |
MEICLNDVQDCXKI
|
6.3 | IC50 | 2 | — | |
MGLUCXBVMSECSF
|
6.3 | IC50 | 2 | — | |
MHGAASPNGOGEDS
|
6.3 | IC50 | 2 | — | |
MLSWYUHRWRDHOM
|
6.3 | IC50 | 2 | — | |
MVVKPRUPEDLLPO
|
6.3 | IC50 | 2 | — | |
MVVKPRUPEDLLPO
|
6.3 | IC50 | 2 | — | |
MXNVBUSFDVBNKE
|
6.3 | IC50 | 2 | — | |
MXNVBUSFDVBNKE
|
6.3 | IC50 | 2 | — | |
MXUKYILIVHOIAT
|
6.3 | IC50 | 2 | — | |
MYBLXMSHAQGUKP
|
6.3 | IC50 | 2 | — | |
NBVYUZFUTMXNCE
|
6.3 | IC50 | 2 | — | |
NJBINXNEZXTEEF
|
6.3 | IC50 | 2 | — | |
NPGFMYBWRAZKTE
|
6.3 | IC50 | 2 | — | |
NPXXPPLEXHVUNL
|
6.3 | IC50 | 2 | — | |
NRLSFKJDXVIOHG
|
6.3 | IC50 | 2 | — | |
OAOSNSJCBYJYDS
|
6.3 | IC50 | 2 | — | |
OAOSNSJCBYJYDS
|
6.3 | IC50 | 2 | — | |
OAOSNSJCBYJYDS
|
6.3 | IC50 | 2 | — | |
OMXFZOWDRIYWJW
|
6.3 | IC50 | 2 | — | |
OPOWURWRVDWEMN
|
6.3 | IC50 | 2 | — | |
OURRBYBBTAZDQT
|
6.3 | IC50 | 2 | — | |
PCCABMXFJJRQOH
|
6.3 | IC50 | 2 | — | |
PCCDWXRGXLUYAL
|
6.3 | IC50 | 2 | — | |
PCZZNGOGBOFHDH
|
6.3 | IC50 | 2 | — | |
PDMLCIQCPWTDKE
|
6.3 | IC50 | 2 | — | |
PETPGGISAKDREI
|
6.3 | IC50 | 2 | — | |
PFQXCKFMFQBLDX
|
6.3 | IC50 | 2 | — | |
PFQXCKFMFQBLDX
|
6.3 | IC50 | 2 | — | |
PFQXCKFMFQBLDX
|
6.3 | IC50 | 2 | — | |
PFSDUOIFCLVAKJ
|
6.3 | IC50 | 2 | — | |
PFVPJXVNIZGSLW
|
6.3 | IC50 | 2 | — | |
PHRRNVORMXLDHF
|
6.3 | IC50 | 2 | — | |
PLYLSSUXEASPAH
|
6.3 | IC50 | 2 | — | |
PMBXYLDEHKOQRB
|
6.3 | IC50 | 2 | — | |
PNYGMYJXPFAURS
|
6.3 | IC50 | 2 | — | |
PUEJOUIDAIDOOV
|
6.3 | IC50 | 2 | — | |
PUWOTIIRZCDDGP
|
6.3 | IC50 | 2 | — | |
PUXLYBQPSZETSB
|
6.3 | IC50 | 2 | — | |
PXRRBFPVJJURRK
|
6.3 | IC50 | 2 | — | |
PXTFALVTAUEBJI
|
6.3 | IC50 | 2 | — |